sp nudging up will we c 60c this month, page-4

Sounds as though ABN Amro are covering themselves as they haven't had much luck in their predictions over the past few years with VCR. Fancy halving their recomendation price to the mid 60s.....even though they are predicting cummulative implant numbers of 300-400 by mid year.

The half yearly should shed some light on operations and if all is going well then I'd expect to hear some extremely positive news.

VCR need to give us more clarity on;
1. the US trials.
2. Whats the hold-up with DT uncond. approval.
3. How many implants done in each trial (BTT & DT).
4. How many centers up and running.

5. European operations
6. Whats the story with the BRACE study
7. How many sales in the EU

8. Device news
9. Reimbursement news throughout all regions particularly in the EU.
10. Asian operations

Lets see what they actually give us in a couple of weeks.